Brief: Cerevel Therapeutics Reports Third Quarter Financial Results
Nov 8 (Reuters) - Cerevel Therapeutics Holdings Inc
CERE.O :
* CEREVEL THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND BUSINESS UPDATES
* QTRLY LOSS PER SHARE $0,66
* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES OF $1,030
MILLION AS OF SEPT 30
* Q3 EARNINGS PER SHARE VIEW $-0.62 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5zyzwM
Further company coverage: CERE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cerevel Therapeutics Holdings
See all newsBrief: Abbvie Reaffirms FY Adj Diluted EPS Guidance Range $10.71-$10.91
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands